Prolactin response to dl-fenfluramine in panic disorder

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Panic disorder is a debilitating condition characterized by recurrent, unexpected panic attacks.
• The role of serotonin in mood disorders, including panic disorder, is an area of ongoing research.
• Serotonin receptors are implicated in the regulation of mood and anxiety.

Purpose of the Study:

• To investigate the hypothesis of hypersensitive serotonin receptors in individuals with panic disorder.
• To examine the neuroendocrine response to fenfluramine as a probe of serotonin receptor function.
• To compare prolactin release patterns between patients with panic disorder and healthy controls.

Main Methods:

• A single oral dose of dl-fenfluramine (60 mg) was administered to 11 patients with panic disorder and 12 healthy controls.
• Blood samples were collected serially (every 30 minutes) over a 6-hour period following drug administration.
• Plasma prolactin levels were quantified using radioimmunoassay.

Main Results:

• Fenfluramine administration led to an increase in plasma prolactin concentrations in both patient and control groups.
• Patients with panic disorder demonstrated a significantly greater elevation in prolactin levels compared to healthy controls.
• The enhanced prolactin response in patients suggests increased serotonin receptor activity.

Conclusions:

• The findings support the hypothesis of increased serotonin receptor function in panic disorder.
• This hypersensitivity may contribute to the pathophysiology of panic disorder.
• Further research is warranted to explore the therapeutic implications of targeting serotonin pathways in panic disorder.